The effectiveness of dapagliflozin and lixisenatide in managing Type 2 diabetes: a real-world observational study

被引：0
|
作者：
Duffy, A. [1 ]
Smith, C. [1 ]
Harrow, C. [1 ]
McGowan, N. [1 ]
McIntyre, M. [1 ]
So, B. [1 ]
Jones, C. [2 ]
Gonzalez, N. [1 ]
机构：
[1] Royal Alexandra Hosp, Dept Endocrinol, Paisley, Renfrew, Scotland
[2] Inverclyde Royal Hosp, Dept Endocrinol, Greenock, Scotland
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P437
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [21] Real-World Use of Dapagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Spaic, Tamara
    Harris, Stewart B.
    Mequanint, Selam
    Reichert, Sonja
    Miller, Kristina
    DIABETES, 2017, 66 : A327 - A328
  • [22] Real-world effectiveness of imeglimin in patients with type 2 diabetes: A retrospective longitudinal study in Japan
    Katsuyama, Hisayuki
    Hakoshima, Mariko
    Heshiki, Takahiro
    Iida, Sakura
    Adachi, Hiroki
    Yanai, Hidekatsu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 213
  • [23] Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
    Bellido, Diego
    Abellan, Pablo
    Palomar, Jose Manuel Ruiz
    Sintes, Rogelio Alvarez
    Nubiolae, Andreu
    Bellido, Virginia
    Romero, Gracia
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2018, 89 : 37 - 42
  • [24] Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom
    Feher, Michael
    Vega-Hernandez, Gabriela
    Mocevic, Emina
    Buysse, Brian
    Myland, Melissa
    Power, Geraldine S.
    Husemoen, Lise L. Nystrup
    Kim, Joseph
    Witte, Daniel R.
    DIABETES THERAPY, 2017, 8 (02) : 417 - 431
  • [25] A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
    Hideaki Miyoshi
    Mike Baxter
    Takeshi Kimura
    Masakatsu Hattori
    Yukiko Morimoto
    Dion Marinkovich
    Masami Tamiwa
    Takahisa Hirose
    Diabetes Therapy, 2021, 12 : 1341 - 1357
  • [26] A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
    Miyoshi, Hideaki
    Baxter, Mike
    Kimura, Takeshi
    Hattori, Masakatsu
    Morimoto, Yukiko
    Marinkovich, Dion
    Tamiwa, Masami
    Hirose, Takahisa
    DIABETES THERAPY, 2021, 12 (05) : 1341 - 1357
  • [27] Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom
    Michael Feher
    Gabriela Vega-Hernandez
    Emina Mocevic
    Brian Buysse
    Melissa Myland
    Geraldine S. Power
    Lise L. Nystrup Husemoen
    Joseph Kim
    Daniel R. Witte
    Diabetes Therapy, 2017, 8 : 417 - 431
  • [28] Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care
    Orozco-Beltran, D.
    Mata-Cases, M.
    Artola-Menendez, S.
    Alvarez-Guisasola, F.
    Cebrian-Cuenca, A. M.
    Perez, A.
    PRIMARY CARE DIABETES, 2025, 19 (01) : 7 - 14
  • [29] Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study
    Bipin Sethi
    Rakesh Sahay
    Mangesh Tiwaskar
    Vijay Negalur
    Rajnish Dhediya
    Kumar Gaurav
    Rahul Rathod
    Bhavesh Kotak
    Gauri Dhanaki
    Snehal Shah
    Drugs - Real World Outcomes, 2024, 11 : 81 - 90
  • [30] Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study
    Sethi, Bipin
    Sahay, Rakesh
    Tiwaskar, Mangesh
    Negalur, Vijay
    Dhediya, Rajnish
    Gaurav, Kumar
    Rathod, Rahul
    Kotak, Bhavesh
    Dhanaki, Gauri
    Shah, Snehal
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (01) : 81 - 90
12345